Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetics and Pharmacokinetics of Oxycodone to Personalize Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

NCT05452694 is registered in ClinicalTrials.gov with OpalGenix, Inc as lead sponsor.

NCT NCT05452694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetics and Pharmacokinetics of Oxycodone to Personalize Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
Lead sponsor
OpalGenix, Inc
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2022
Completion date
July 1, 2027
Enrollment
235 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar spine degeneration, lumbar spine stenosis